SEB Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.9M Buy
1,645,819
+42,846
+3% +$1.14M 0.17% 114
2026
Q2
$38.6M Buy
1,602,973
+270,803
+20% +$7.08M 0.15% 131
2026
Q1
$37.4M Buy
+1,332,170
New +$35.5M 0.16% 118

Other funds holding PFE

SEB Asset Management's PFE Position: Q3 2026 in Review

SEB Asset Management increased its Pfizer (PFE) stake by 2.7% in Q3 2026, buying an estimated $1.14M and bringing the position to 1,645,819 shares worth $46.9M. The position accounts for 0.17% of the portfolio, ranked #114.

SEB Asset Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • SEB Asset Management held 1,645,819 shares of Pfizer worth $46.9M as of Q3 2026.
  • SEB Asset Management bought 42,846 Pfizer shares in Q3 2026, an estimated $1.14M.
  • Pfizer made up 0.17% of SEB Asset Management's portfolio in Q3 2026, its #114 holding.
  • SEB Asset Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.